Back to Search
JACEK PINSKI, M.D.
M.D.
Medical Oncology Physician
NPI: 1720014160IndividualAccepts Medicare
Specialties, Licenses & Credentials
Education
OTHER
Class of 1987
Research & Publications (20)
Genistein-induced neuroendocrine differentiation of prostate cancer cells.
PMID 16652383·Prostate·2006
8-other
Prostate cancer metastases to bone: pathophysiology, pain management, and the promise of targeted therapy.
PMID 15808959·Eur J Cancer·2005
6-review
Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial.
PMID 19213668·Clin Genitourin Cancer·2009
3-trial
Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells.
PMID 18814146·Prostate·2009
8-other
A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer.
PMID 18782306·BJU Int·2008
3-trial
Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer.
PMID 18651557·Prostate·2008
8-other
Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival.
PMID 17640713·Hum Pathol·2007
8-other
The AKT inhibitor perifosine in biochemically recurrent prostate cancer: a phase II California/Pittsburgh cancer consortium trial.
PMID 18272025·Clin Genitourin Cancer·2007
3-trial
Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer.
PMID 16697447·Urology·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1441 EASTLAKE AVE
LOS ANGELES, CA 90089 - Phone
- (323) 865-3000
Quick Facts
- NPI
- 1720014160
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile